Drawing for Serial No. 99402638

USPTO serial 99402638

Serial No. 99402638

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
KNIGHT, TROY FRANK
Law office
TMEG LAW OFFICE 107

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 99402638?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Fara S. Sunderji

Fara S. Sunderji Dorsey & Whitney LLP51 West 52nd StreetNew York, NY 10019-6119United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonistsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 10, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 10, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Aug 10, 2026CNSLSUSPENSION LETTER WRITTEN—
May 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 19, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance